Side by Side
Compare
Read two to four stocks on the same scale — return, valuation and volatility in one table.
Selected6M Return
Period Return
Each series is converted to a percentage of its own starting point, so all of them begin at zero. What is compared is the return over the period, not price levels.
| Metric | AKRO | MRNA | BACK |
|---|---|---|---|
| Return | |||
| Last Price | 54.70 | 145.78 | 0.13 |
| Daily Change | — | − 2.08% | — |
| Period ReturnPast 6 Months | — | + 181.51% | 0.00% |
| Valuation | |||
| Market Cap | $4.50 B | $57.8 B | $1.89 K |
| P/E Ratio | — | — | — |
| Dividend Yield | — | — | — |
| Net MarginTrailing 12M | — | 141.4% | 23,232.4% |
| Risk | |||
| Beta | — | 1.22 | -1.12 |
| 52-Week Range | — | 22.28 — $176.66 | 0.00 — $0.21 |
| Company | |||
| Sector | — | Health Care | — |
| Industry | Biotechnology | Biotechnology | Biotechnology |
Company
- AKROBiotechnology
- MRNAHealth Care · Biotechnology
- BACKBiotechnology
Metrics could not be loaded for AKRO: P/E, dividend, beta and the 52-week range stay empty in that column.
Alpaca · SIPUpdated 20:5315 Minutes Delayed
To Understand This